OptiNose (OPTN) Schedule 13G/A: Filing Shows 0 Shares Owned
Rhea-AI Filing Summary
Schedule 13G/A filing by Nantahala Capital Management, LLC and two individuals reporting zero beneficial ownership in OptiNose, Inc. The filing states that as of June 30, 2025, Nantahala and its managing members, Wilmot B. Harkey and Daniel Mack, may be deemed beneficial owners of 0 shares of OptiNose common stock (CUSIP 68404V209), representing 0.00% of the class. The filing identifies Nantahala as an investment adviser organized in Massachusetts and lists the reporting persons' business address in New Canaan, Connecticut. Signatures include Nantahala through its Chief Compliance Officer and both individual reporting persons, dated August 14, 2025.
Positive
- Complete disclosure of reporting persons, addresses, and CUSIP with signed certifications dated August 14, 2025
Negative
- None.
Insights
TL;DR: The filing shows no economic stake by the reporting persons in OPTN, so there is no ownership-driven influence on the company.
The Schedule 13G/A discloses that Nantahala Capital Management and its named managers hold 0 shares (0.00%) of OptiNose as of June 30, 2025. For investors and analysts, this is a routine ownership disclosure indicating the filer is not a shareholder and therefore not an active investor exerting voting or dispositive influence. There are no financial metrics, transactions, or changes in ownership reported that would affect valuation or control.
TL;DR: Filing appears complete and compliant: reporting persons certified ordinary-course holdings and executed signatures.
The document classifies Nantahala as an investment adviser and includes the required certification that the securities, if any, are held in the ordinary course of business. All required identification fields are provided, including issuer address and CUSIP. The signed certifications dated August 14, 2025, satisfy typical Schedule 13G/A formalities. Because no shares are reported, there is no disclosure of group formation, material influence, or Section 13(d) activity to assess for risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Schedule 13G/A filed for OPTN disclose?
Who filed the Schedule 13G/A for OptiNose (OPTN)?
When is the ownership measurement date reported in the Schedule 13G/A?
Does the Schedule 13G/A indicate Nantahala has control or a group with other holders?
Were the required signatures provided on the Schedule 13G/A for OPTN?
AI-generated analysis. How Rhea-AI works. Not financial advice.